Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Neoplasms | 7 | 2026 | 87 | 2.260 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2026 | 734 | 1.410 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 4 | 2019 | 33 | 1.260 |
Why?
|
| Serine-Arginine Splicing Factors | 2 | 2019 | 14 | 0.730 |
Why?
|
| Carcinogenesis | 2 | 2021 | 135 | 0.710 |
Why?
|
| Carcinoma, Papillary | 2 | 2020 | 37 | 0.690 |
Why?
|
| RNA Splicing | 2 | 2019 | 171 | 0.690 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2020 | 9 | 0.660 |
Why?
|
| Transcriptome | 2 | 2021 | 399 | 0.610 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2019 | 314 | 0.610 |
Why?
|
| Alternative Splicing | 4 | 2018 | 138 | 0.590 |
Why?
|
| Repressor Proteins | 1 | 2020 | 351 | 0.530 |
Why?
|
| Germ-Line Mutation | 3 | 2026 | 47 | 0.420 |
Why?
|
| DNA Damage | 3 | 2015 | 298 | 0.420 |
Why?
|
| Nuclear Proteins | 2 | 2015 | 790 | 0.390 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2021 | 512 | 0.380 |
Why?
|
| Cell Line, Tumor | 5 | 2020 | 1568 | 0.380 |
Why?
|
| Pedigree | 4 | 2026 | 193 | 0.350 |
Why?
|
| Genome-Wide Association Study | 4 | 2021 | 364 | 0.340 |
Why?
|
| RNA-Binding Proteins | 1 | 2015 | 446 | 0.340 |
Why?
|
| Haplotypes | 2 | 2020 | 135 | 0.310 |
Why?
|
| Genotype | 3 | 2020 | 674 | 0.310 |
Why?
|
| Alleles | 2 | 2020 | 455 | 0.290 |
Why?
|
| Whole Genome Sequencing | 2 | 2026 | 87 | 0.260 |
Why?
|
| Genetic Linkage | 1 | 2026 | 97 | 0.230 |
Why?
|
| Rhabdomyosarcoma | 2 | 2015 | 15 | 0.210 |
Why?
|
| Protein Interaction Maps | 2 | 2020 | 35 | 0.180 |
Why?
|
| Humans | 15 | 2026 | 65498 | 0.180 |
Why?
|
| Spherocytosis, Hereditary | 1 | 2021 | 1 | 0.170 |
Why?
|
| Spectrin | 1 | 2021 | 8 | 0.170 |
Why?
|
| RNA Splice Sites | 1 | 2021 | 22 | 0.170 |
Why?
|
| Thyroid Gland | 1 | 2021 | 83 | 0.170 |
Why?
|
| Telomere-Binding Proteins | 1 | 2020 | 6 | 0.160 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 2020 | 6 | 0.160 |
Why?
|
| Linkage Disequilibrium | 1 | 2020 | 47 | 0.160 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 86 | 0.150 |
Why?
|
| Telomere | 1 | 2020 | 58 | 0.150 |
Why?
|
| Mutation, Missense | 1 | 2020 | 190 | 0.140 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2018 | 37 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 1 | 2018 | 129 | 0.140 |
Why?
|
| Biomarkers, Tumor | 2 | 2019 | 526 | 0.130 |
Why?
|
| Photoreceptor Cells | 1 | 2016 | 18 | 0.130 |
Why?
|
| Xenopus Proteins | 1 | 2016 | 38 | 0.120 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2016 | 38 | 0.120 |
Why?
|
| Eye Proteins | 1 | 2016 | 73 | 0.120 |
Why?
|
| Protein Isoforms | 2 | 2014 | 201 | 0.120 |
Why?
|
| Melanoma | 1 | 2020 | 333 | 0.120 |
Why?
|
| Male | 8 | 2026 | 31208 | 0.120 |
Why?
|
| Stress, Physiological | 2 | 2015 | 210 | 0.120 |
Why?
|
| Female | 8 | 2026 | 34216 | 0.110 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2015 | 9 | 0.110 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2015 | 16 | 0.110 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 277 | 0.110 |
Why?
|
| MCF-7 Cells | 1 | 2015 | 65 | 0.110 |
Why?
|
| Exons | 1 | 2015 | 208 | 0.100 |
Why?
|
| HeLa Cells | 1 | 2015 | 541 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2016 | 663 | 0.090 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 344 | 0.090 |
Why?
|
| Middle Aged | 6 | 2024 | 18393 | 0.070 |
Why?
|
| Transcription Factors | 1 | 2016 | 1557 | 0.070 |
Why?
|
| Adult | 5 | 2024 | 17467 | 0.060 |
Why?
|
| Animals | 3 | 2019 | 21394 | 0.060 |
Why?
|
| Mice | 1 | 2019 | 11145 | 0.060 |
Why?
|
| Pyruvate Dehydrogenase (Lipoamide)-Phosphatase | 1 | 2024 | 3 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2014 | 3156 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2021 | 1039 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2024 | 109 | 0.050 |
Why?
|
| Mutation | 2 | 2021 | 2666 | 0.040 |
Why?
|
| Microarray Analysis | 1 | 2021 | 65 | 0.040 |
Why?
|
| Pacific Islands | 1 | 2021 | 4 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2021 | 124 | 0.040 |
Why?
|
| Heterozygote | 1 | 2021 | 173 | 0.040 |
Why?
|
| Chromosomes, Human | 1 | 2021 | 52 | 0.040 |
Why?
|
| Aged | 3 | 2021 | 15062 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2021 | 285 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 5650 | 0.040 |
Why?
|
| Computational Biology | 1 | 2021 | 368 | 0.040 |
Why?
|
| RNA Precursors | 1 | 2018 | 78 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 586 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1143 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 796 | 0.030 |
Why?
|
| Phenotype | 1 | 2021 | 1233 | 0.030 |
Why?
|
| Genes, Homeobox | 1 | 2016 | 24 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2016 | 27 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2016 | 61 | 0.030 |
Why?
|
| Xenopus laevis | 1 | 2016 | 72 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2019 | 485 | 0.030 |
Why?
|
| In Situ Hybridization | 1 | 2016 | 213 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2016 | 363 | 0.030 |
Why?
|
| Apoptosis | 1 | 2021 | 1098 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2016 | 513 | 0.030 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2014 | 47 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 687 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 196 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2014 | 181 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 2013 | 218 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2016 | 908 | 0.020 |
Why?
|
| Child | 1 | 2021 | 4623 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 2307 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2013 | 404 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 1577 | 0.020 |
Why?
|
| Adolescent | 1 | 2021 | 6333 | 0.020 |
Why?
|
| Neoplasms | 1 | 2014 | 1372 | 0.010 |
Why?
|